Skip to main content
Ann Navar, MD, Cardiology, Dallas, TX

AnnMarieNavarMDPhD, FACC, FAHA, FASCP

Cardiology • Dallas, TX

Preventive Cardiology

Physician

Join to view full profile

Dr. Navar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Navar's full profile

Already have an account?

  • Office

    5323 Harry Hines Boulevard
    Dallas, TX 75390
    Phone+1 214-633-5555
    Fax+1 214-645-6757

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 2013 - 2016
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine/Pediatrics, 2009 - 2013
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2009

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2020 - 2024
  • NC State Medical License
    NC State Medical License 2009 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Journal Articles

  • Choosing an Initial Therapeutic Approach for Hypertension—Time for a Fixed-Dose Combination First?  
    Ann Marie Navar, Thomas J Wang, JAMA Cardiology
  • Heroism in the Face of the COVID-19 Pandemic  
    Ajay J Kirtane, Ann Marie Navar, JAMA Cardiology
  • Moving Beyond Regression Techniques in Cardiovascular Risk Prediction: Applying Machine Learning to Address Analytic Challenges  
    Ann Navar, MD, European Heart Journal

Abstracts/Posters

  • [Board 414] Triglycerides as a Risk Factor For Coronary Heart Disease: What Measure and What Cutoff?
    Ann Navar, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/18/2019

Lectures

  • Deep Dive II 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Authored Content

  • How Real-World Data Augments What We Know About SGLT-2 Inhibitors for Cardiovascular Risk ReductionSeptember 2020
  • Choosing an Initial Therapeutic Approach for Hypertension—Time for a Fixed-Dose Combination First?July 2020
  • Heroism in the Face of the COVID-19 PandemicJune 2020

Press Mentions

  • Apolipoprotein B Test May Be More Accurate Measure of Heart Disease Risk
    Apolipoprotein B Test May Be More Accurate Measure of Heart Disease RiskAugust 14th, 2024
  • Pregnant Cardiology Trainees Report High Complication Rates, Lack of Radiation Safety
    Pregnant Cardiology Trainees Report High Complication Rates, Lack of Radiation SafetyAugust 9th, 2024
  • Fish Oil Labels Make Health Claims, Despite Lack of Data
    Fish Oil Labels Make Health Claims, Despite Lack of DataSeptember 18th, 2023
  • Join now to see all

Other Languages

  • Spanish

Dr. Ann Navar, Dr. Ann Navar, MD, Dr. A Navar, Dr. Ann Marie Navar